Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Liquidia Corporation - Common Stock
(NQ:
LQDA
)
34.03
-1.23 (-3.49%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Liquidia Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 03, 2024
Via
Benzinga
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
↗
June 03, 2024
Liquidia stock retook its 50-day line Monday on a U.S. judge's ruling on a patent dispute with fellow biotech company United Therapeutics.
Via
Investor's Business Daily
Topics
Intellectual Property
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
↗
June 03, 2024
Via
Benzinga
7 Analysts Have This To Say About Liquidia
↗
June 03, 2024
Via
Benzinga
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
June 03, 2024
From
Liquidia Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 31, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 14, 2024
Via
Benzinga
LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q1 2024
↗
May 14, 2024
LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
The Analyst Landscape: 5 Takes On Liquidia
↗
April 01, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On Liquidia
↗
March 13, 2024
Via
Benzinga
Recap: iShares $ Corp Bond UCITS ETF Q4 Earnings
↗
March 13, 2024
Via
Benzinga
Topics
ETFs
Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference
May 29, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
May 15, 2024
Via
Benzinga
Liquidia Earnings Preview
↗
March 12, 2024
Via
Benzinga
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
May 10, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
May 07, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
May 07, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
↗
April 25, 2024
"Mad Money Lightning Round," Jim Cramer recommended buying Cloudflare. "I would buy it slowly because we've got big selling going on in AI stock Meta," he added.
Via
Benzinga
Topics
Artificial Intelligence
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
April 01, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
March 27, 2024
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
March 18, 2024
Via
Benzinga
Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday
↗
March 14, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Thursday.
Via
Benzinga
Topics
Stocks
Earnings Scheduled For March 13, 2024
↗
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via
Benzinga
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
March 13, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
March 06, 2024
From
Liquidia Corporation
Via
GlobeNewswire
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
↗
February 21, 2024
Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the implications on PH-ILD, potential 30-month stay, and recent financial...
Via
Benzinga
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
↗
February 12, 2024
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:
Via
Benzinga
Topics
Intellectual Property
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
January 30, 2024
From
Liquidia Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today